Details of the Drug

General Information of Drug (ID: DMU3HYY)

Drug Name
EBV-CTL
Indication
Disease Entry ICD 11 Status REF
Post-transplant lymphoproliferative disorder 2B32 Phase 2 [1]
Cross-matching ID
TTD ID
D0CG1A

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)